Investigating the effects of opioid use during pregnancy on fetal and placental health
Multimodal Fetal and Placental Imaging and Biomarkers of Clinical Outcomes in Opioid Use Disorder
This study is looking at how using opioids during pregnancy can impact the health of both the baby and the placenta, using special imaging and tests to find early signs of any problems, so we can help moms and their little ones stay healthier.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10750306 on NIH RePORTER |
What this research studies
This research focuses on understanding how maternal opioid use disorder affects fetal and placental health through advanced imaging techniques and biomarkers. It aims to identify early predictors of adverse outcomes for both mothers and infants exposed to opioids during pregnancy. By utilizing longitudinal and serial imaging, the study will assess changes in placental morphology and fetal development, providing insights into the risks associated with prenatal opioid exposure. The findings could lead to better management strategies for pregnant women with opioid use disorder and their infants.
Who could benefit from this research
Good fit: Ideal candidates for participation include pregnant women with a history of opioid use disorder and their infants.
Not a fit: Patients who are not pregnant or those without any history of opioid use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prediction and management of health outcomes for mothers and infants affected by opioid use during pregnancy.
How similar studies have performed: Previous studies have shown promising results in understanding the impacts of prenatal opioid exposure, indicating that this research builds on established findings.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Radhakrishnan, Rupa — Indiana University Indianapolis
- Study coordinator: Radhakrishnan, Rupa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.